Introduction
Rabbit Haemorrhagic Disease Virus (RHDV; Caliciviridae) was introduced into rabbit-control programs in Australia and New Zealand in 1995-97 as a biological control agent for reducing the detrimental impacts of European rabbits (Oryctolagus cuniculus) on agricultural production and/or the environment (Kovaliski 1998; Neave 1999; O'Keefe et al. 1999; Cooke et al. 2000) . However, there is now mounting evidence that a non-virulent RHDV-like virus (nvRHDV-LV) was present in wild rabbit populations before the introduction of virulent RHDV in south-eastern Australia (Cooke et al. 2000 Nagesha et al. 2000; Robinson et al. 2002) and New Zealand (O'Keefe et al. 1999; Nagesha et al. 2000) . This finding is based mainly on serological evidence where individual rabbits had a low titre, or were seronegative, for the 1 :10 cELISAs for RHDV antibodies, but had readily detectable levels of IgG as assessed by specific isotype ELISAs. Between 47% and 90% of wild rabbits in these populations, including populations with no known prior exposure to RHDV, are thought to have antibodies to a non-virulent form of RHDV (Nagesha et al. 1995; O'Keefe et al. 1999; Robinson et al. 2002) . nvRHDV-LV(s) is thought to be more prevalent in the higher rainfall areas of Australia. (Cooke et al. 2000 . The presence of pre-existing antibodies to nvRHDV-LV in Australian rabbits often correlates with partial immunity against RHDV (Nagesha et al. 1995 (Nagesha et al. , 2000 Cooke et al. 2000 Cooke et al. , 2002 . It has also been suggested that the apparent persistence of nvRHDV-LV in the higherrainfall areas of south-eastern Australia is one of the major reasons for the reduced effectiveness of RHDV in such regions.
Although the impact of nvRHDV-LV on the epidemiology of RHDV in south-western Australia remains to be clarified, the epidemiology and efficacy of Rabbit Haemorrhagic Disease (RHD) following its natural arrival at Kojaneerup (near Albany) in southern Western Australia suggest that the virus in this region best approximates the behaviour of RHDV in the higher-rainfall areas of south-eastern Australia (Bruce et al. 2004) . Rabbit mortality during the initial September 1996 RHDV epizootic at Kojaneerup was onlỹ 65%, and over 70% of survivors were seropositive in the RHDV cELISA, indicating recent exposure to RHDV (or to
Wildlife Research, 2004, 31, 605-612 nvRHDV-LV). Following the initial 1996 epizootic there was no further clinical evidence of RHDV activity on this site for nearly 3 years. This was despite the recovery of the rabbit population to pre-RHDV levels (ie. a substantial number of naive individuals were present; <10% of rabbits were seropositive in the cELISA), and the ongoing presence of suitable insect vectors (Bruce et al. 2004) . Some rabbits did appear to have been challenged by RHD after the 1996 epizootic; however, most of these exhibited only a transient immune response, with antibody levels declining in as little as six weeks after challenge. IsoELISA analysis of the specific immunoglobins against RHD in these rabbits suggested that the observed serological profile was the result of exposure to nvRHDV-LV. The aim of the current paper is to examine the prevalence of nvRHDV-LV in south-western Australia (i.e. at Kojaneerup, Western Australia), and assess the likely impact of nvRHDV-LV on the overall effectiveness of RHDV as a biological control agent. We also discuss some of the difficulties with interpreting the results of the ELISAs currently used to determine exposure to RHD.
Materials and Methods

Study area
Following the escape of RHDV from Wardang Island in South Australia in September 1995 (Neave 1999 ), a monitoring site was established at Kojaneerup, Western Australia, in July 1996 to study the epidemiology of RHDV before and after the natural arrival of RHDV. Kojaneerup is 80 km north-east of Albany in southern Western Australia (34°32′S, 118°21′E). The site comprised two farming properties: Property 1 was the main farm monitored, and the neighbouring property, Property 2, was monitored less frequently. The changes in rabbit numbers, and their serology, were monitored on the site over a 3-year period. Climate is typically Mediterranean with 485 mm rainfall per annum. Merino sheep and cereal production are the main agricultural enterprises. A general description of the site, and the epidemiology of RHD in this rabbit population, are given in Bruce et al. (2004) .
Rabbit sampling
Thirty rabbits were shot and their sera collected on Property 2 over three nights during July-August 1996, before the known arrival of RHDV. However, the detailed serological profile of the rabbits was mainly determined from rabbits caught during a live-trapping program at Property 1. In total, 986 rabbits were trapped from October 1996, soon after the arrival of RHDV on the site, to August 1999. A 3.0-mL blood sample was taken for serological analysis, and the rabbits released at their point of capture. Each trapped rabbit was tagged and the weight, sex, reproductive condition, and relative flea burden recorded for each trapping session.
Reintroduction (field release) of RHDV
RHDV was reintroduced into the resident rabbit population on Property 1 in April 1999. Fifteen adult rabbits with known serological histories (cELISA) were trapped and inoculated intramuscularly with 0.5 mL suspension of RHDV (1500 × known LD 50 dose; Czech strain V-351, CSIRO Batch RCV-1A). Although the precise serological status of these rabbits could not be determined at this time, their RHD-antibody status was ultimately determined from the sera samples collected on the day of inoculation. Following the inoculations, 7 rabbits, which were considered to be seronegative or equivocal for RHDV antibodies, were immediately released at the trapping site. The remaining 8 were temporarily kept in captivity and monitored for clinical signs of the disease over the next 6 days. Rabbits that survived this captive period (n = 5) were released back at the trapping site. Livers from rabbits that died during this period were tested for the presence of RHDV by antigencapture ELISA (Collins et al. 1996) . Similarly, liver from carcases found on site following the development of the disease were also tested for RHDV antigen. Liver samples of rabbits seropositive for RHDV following the field release were subsequently analysed by RT-PCR and the resulting DNA sequenced. Rabbit serology continued to be monitored from trapped rabbits at Property 1 until August 1999.
ELISA methods
Serum samples were forwarded to the Animal Health Laboratory, Department of Agriculture Western Australia, for competition ELISA (cELISA) (Capucci et al. 1997) . Results were expressed in terms of the percentage inhibition of the optical density of a 1:10 dilution of serum against standard controls (negative and positive) on the same cELISA plate. Rabbits were considered seropositive for RHD antibodies if the sample gave ≥50% inhibition and seronegative if the resultant inhibition was ≤15%. Values between these cut-offs (i.e. 16-49%) were considered equivocal. These cut-offs were deliberately conservative . Sera from rabbits (n = 117) whose serological profile was uncertain, but which appeared to have seroconverted, as well as those inoculated during the RHDV-release experiment, were forwarded to the Waite Institute, Adelaide, for more detailed analysis using an immunoglobulin isotype-specific ELISA (isoELISA: Capucci et al. 1997; Cooke et al. 2000) . It has been suggested that the associated proportions of IgG, IgA and IgM antibody isotypes allows discrimination between exposure to nvRHDV-LV and RHDV. The presence of maternal antibodies, recent and past exposure to RHDV, and instances of reexposure to RHDV can also be determined from these serological profiles (Cooke et al. 2000; Robinson et al. 2002) . The criteria for differentiating between these immunological classes, as recommended by Cooke et al. (2000) , are summarised in Table 1 .
RT-PCR and sequence analysis
Liver samples from rabbits killed by RHDV were forwarded to the Department of Crop Protection, University of Adelaide, for RT-PCR amplification of viral RNA and subsequent DNA sequencing (Asgari et al. 1999) . RNA was extracted from each liver and a 398-bp fragment of the RHDV capsid protein (VP60) gene was amplified by PCR using gene-specific primers. The amplified DNA fragments were sequenced by automated solid-phase DNA sequencing. A 340-bp segment, from nucleotides 6440-6780, was then selected for alignment and comparison with the original Czech strain V-351 (Meyers et al. 1991; Asgari et al. 1999) . Samples were sequenced twice to confirm nucleotide modifications. Table 2 summarises the serology of rabbits shot on Property 2 from July (pre-RHDV) to September 1996, when RHDV was first evident on the site (RHDV arrived ~6 September). Seven of the 30 rabbits (23%) sampled 1-2 months before the arrival of RHDV had cELISAs equivocal for RHDV antibodies. The remainder were seronegative. Subsequent isoELISA testing indicated that 6 of the 7 equivocal sera were seropositive for IgG antibodies to RHDV, with associated cELISA titres ≤1:10, suggesting prior exposure to nvRHDV-LV. There was no clinical evidence of RHDV at this time, and rabbit abundance was at its highest level for some time.
Results
Even after the natural arrival of RHDV, 10% of rabbits (i.e. 98 of 986) trapped at Kojaneerup between September 1996 and August 1999 had a serological profile consistent with the presence of nvRHDV-LV. Over half (n = 60) of these appeared to have been challenged by nvRHDV-LV at some time over this period. On the basis of their serological profile, it is likely that the remaining 38 rabbits were exposed to nvRHDV-LV before the natural arrival of RHDV. However, 34% of trapped rabbits (i.e. 340 of 986) showed variable cELISA titres that ranged from 15% to 80% inhibition, without any associated clinical evidence of RHDV challenge or the presence of declining maternal antibodies to RHDV. This may more accurately reflect the overall extent of challenge by nvRHDV-LV at this site.
Fewer than 1% of rabbits (i.e. 9 of 986) showed serological evidence of challenge by RHDV during the 30 months after the initial 1996 epizootic. Most seropositive rabbits were seen between April and December 1998. However, none of these rabbits developed an immune response comparable to that of rabbits exposed to RHDV during the 1996 epizootic or during the 1999 reintroduction of RHDV. Rabbits that survived RHDV challenge during these two epizootics generally developed cELISA titres >1 :160 and IgG isoELISA titres >1 :9000 (Table 3) . Rabbits challenged by RHDV at these times also had cELISAs with ≥80% inhibition, with little evidence of declining antibody levels over the study period. Further, following the initial epizootic, no clinical signs of the disease were apparent in the population until RHDV was reintroduced in April 1999. Examples of serological profiles of rabbits indicative of exposure to RHDV and nvRHDV-LV are shown in Table 3 . Rabbit L1 shows evidence of RHDV challenge during the initial 1996 epizootic, and Rabbits 4099 and 5045 show evidence of nvRHDV-LV challenge well after the 1996 RHDV epizootic. Rabbits 4014 and 4099 were challenged by RHDV well after the natural epizootic in 1996. The serological profiles of Rabbits 5045 and 4872 indicate that they were challenged by RHDV following the field release in April 1999 (Table 3) .
The pre-release serology, and subsequent survival, of the rabbits inoculated with RHDV during the field release in April 1999 are shown in Table 4 . Three of the 8 inoculated rabbits retained for monitoring died within 96 h. All 3 rabbits had antibodies to nvRHDV-LV immediately before inoculation. Only 1 of the 6 survivors was found to be seropositive for RHDV at the time of inoculation, and the remaining 5 surviving rabbits had serological profiles indicative of exposure to nvRHDV-LV (Table 4) . Only 1 of the 7 rabbits released immediately after inoculation was retrapped after inoculation. Within 8 weeks of the field release, rabbit mortality over the entire site was estimated at ~65% (on the basis of spotlight counts and the trapping program). Of the surviving rabbits trapped over this period (n = 131), only 15% showed evidence of recent RHDV challenge (cELISA and isoELISA), indicating that ~30% of the total population had not been challenged by the virus during this period.
Seven rabbits whose serological status was also determined <3 weeks before challenge showed evidence of recent RHDV infection following the field release of the virus. Five of these rabbits had died and were found to be positive for RHDV antigen. Two survived but had a serological profile indicative of recent RHDV infection. This included inoculated Rabbit 4872, which was recaptured after inoculation. Both these survivors, and 4 of the 5 rabbits that had died, showed serological evidence of exposure to nvRHDV-LV before the release. Although the 7 rabbits that survived RHDV challenge following the field release had variable cELISA titres, all 7 showed IgG titres ≥1:2560 before chalEvidence of a non-virulent RHDV-like virus in Western Australia IsoELISAs were conducted only for those rabbits with >15% cELISA result (i.e. equivocal or positive).
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lenge. Conversely, the 8 rabbits that died from RHDV had negative cELISA titres and IgG titres ≤1:2560 before challenge (Table 4) . Examination of the serological profiles of rabbits whose antibody isotypes were determined (isoELISA) showed that at least 18% (21 of 117) were probably misclassified, on the basis of the criteria of Cooke et al. (2000) (see Tables 1 and  5 ). Thirteen rabbits were originally classified as having been recently challenged by RHDV on the basis of their high IgM and IgA antibody titres and their positive cELISA. However, on subsequent sampling, all 13 rabbits were classified as having been exposed to nvRHDV-LV (based on their serological profiles). None developed cELISA titres greater than 1:40 and IgG titres remained relatively low (<1 :640). These challenges occurred between June 1997 and December 1998, with most occurring in June and November 1998. A further eight rabbits showed variable serological profiles, whose interpretation alternated between virulent and non-virulent RHDV over time. All showed cELISAs titres ≤1:40 (Table 5) .
The PCR-amplified sequences of DNA derived from the virus isolated from dead rabbits positive for RHDV antigen following the field release in April 1999 showed minor variation from the sequences derived from the original Czech strain (Table 6 ). Although no nucleotide insertions or deletions were observed, several substitutions were evident. One rabbit had a sequence that was 1.5% divergent from that of the Czech strain within three weeks of release. Samples collected in June 1999 from the release site and at Two Peoples Bay (40 km south-west of the release site) showed similar levels of, but not identical, nucleotide substitution (Table 6 ).
Discussion
Several authors have argued that rabbits infected with the non-virulent and virulent forms of RHDV can be distinguished on the basis of their serological profile (Capucci et al. 1997 , Cooke et al. 2000 Nagesha et al. 2000; Robinson et al. 2002) . We are confident that RHDV challenge can be identified from the serological profiles of rabbits where the cELISAs consistently show more than 80% inhibition values , particularly as the titres of such cELISAs are often >1 :160. However, the sera of rabbits believed to be infected with nvRHDV-LV generally have low reactivity for RHDV cELISAs, but relatively high IgG titres during specific-isotype ELISAs. Such profiles most likely reflect differences in the surface antigens (proteins) of the two forms of calicivirus, as the outer 'shell' appears to differ between these viruses, and to that of the avirulent rabbit calicivirus in Europe (Capucci et al. 1996 (Capucci et al. , 1997 . Mortality of such individuals when exposed to RHDV can also be reduced (Capucci et al. 1996 (Capucci et al. , 1997 Cooke et al. 2000 Cooke et al. , 2002 Robinson et al. 2002) . The immune response of at least 10% of our rabbits displayed a serological profile consistent with the presence of a non-virulent strain of RHDV, or some other avirulent calicivirus, at our site. Further, the proportion of rabbit sera from this population classified as equivocal for the cELISA was often very high, and ranged from 20% to over 70% of sampled rabbits over the 3-year study (Bruce et al. 2004 ). This provides additional circumstantial evidence that interaction between one or more RHDV-like viruses and RHDV may be occurring at the Kojaneerup site.
Further support for the presence of nvRHDV-LV in southwestern Australia is also demonstrated by the serological profile of rabbit sera collected within 12 km of our current site during an unrelated study from 1992 to 1996 (Twigg et al. 2000) . These sera, which were collected to determine the antibody status to myxoma virus, were reassayed for RHDV antibodies. Two specific ELISAs were used: a cELISA that tested for exposure to surface epitopes of the RHDV capsid proteins, and a second ELISA that tested for exposure to an internal capsid protein epitope. Sera testing positive for both ELISAs most likely result from exposure to RHDV, while sera negative to the cELISA but positive for the internal epitope are most likely the result of exposure to nvRHDV-LV. Approximately 70% of the 101 sera samples assayed indicated exposure to nvRHDV-LV (L. Capucci, L. Twigg & A. Robinson, unpublished data) . The reassayed samples were collected in 1993/94, which preceded the natural arrival of RHDV in Western Australia by 2-3 years.
The above findings provide further support for the presence of a nvRHDV-LV in Australia. A nvRHDV-LV(s) has also been suggested in rabbits from eastern Australia before the introduction of RHDV , and nvRHDV-LV is also believed to be present in New Zealand rabbits (O'Keefe et al. 1999) . A non-virulent form of calicivirus of lagomorphs, rabbit calicivirus, is also known to occur throughout much of Europe (Capucci et al. 1996; White et al. 2001; Moss et al. 2002) . However, the non-virulent form(s) of RHDV in Australia is yet to be isolated and characterised. The isolation and characterisation of such a virus will be difficult as there are now likely to be attenuated strains of RHDV in Australian rabbits. Further, attenuated viruses with low host mortalities can be difficult to find because there may be little clinical evidence of their activity.
RHDV appears to have undergone some genetic change at Kojaneerup, Western Australia, and elsewhere in Australia since its escape in 1995 (Asgari et al. 1999) . However, given that PCR products were sequenced rather than a consensus sequence derived from cDNAs, the biological significance of such changes (e.g. attenuation and biological control) are unclear. Such changes may be of minor significance. With the PCR products, the RHDV isolated from rabbits 12 months after RHDV first arrived at Forrestfield and Perenjori in Western Australia had 99% similarity with the original Czech strain, but both these isolates differed from the Kojaneerup 1999 isolate by ~2.4% (Table 6 ; Asgari et al. 1999) . These rates of change are similar to that seen in Evidence of a non-virulent RHDV-like virus in Western Australia Table 4 . Examples of the immunological status of rabbits before their inoculation with, or natural challenge by, RHDV during the field release at Kojaneerup, Western Australia on 16 April 1999 Pre-challenge status is based upon the sera collected on the day of inoculation (inoculated) or the last date sampled before natural challenge; Post-challenge status is based upon the condition of rabbits when next trapped or the recovery of associated carcases. The subsequent survival of these rabbits after release is also shown. N, negative However, a more concerted study would be required to establish the phylogenetic relationships of these viruses.
The differences in the apparent prevalence of nvRHDV-LV at the two sites separated by only 10-12 km in southwestern Australia are difficult to explain (70% v.~34% apparent prevalence before and after the introduction of RHDV). It is possible that the selection pressure associated with nvRHDV-LV in the absence of RHDV (i.e. before introduction of RHDV) differs from that which now occurs in the presence of the virulent virus. Further, it is not unreasonable to assume that nvRHDV-LV has been in Australia for a much longer period than RHDV, and that nvRHDV-LV probably arrived with the original rabbits ~150 years ago. Virulent and non-virulent forms of RHDV are also believed to cocirculate in the same rabbit populations in the United Kingdom (Moss et al. 2002) ; although over a longer time-frame, this may have occurred at our Kojaneerup site in Western Australia. However, there are other possible explanations for many of the above observations. For example, the ELISAs used to separate exposure to the virulent and non-virulent forms of RHDV, or the interpretation of these results, may not be as specific as previously believed, particularly where cELISA titres are below 1 : 40. O' Keefe et al. (1999) also found serological interpretation difficult at such dilutions. Analysis of the serological profiles of our rabbits using the Cooke et al. Cooke et al. (2000) ; see Methods. Table 6 . Examples of sequence variation in the amplified DNA derived from the RNA of the original RHDV virus introduced into Australia (Czech strain V-351) and from the RHDV found in dead wild rabbits following its arrival in Western Australia Comparisons were based on the partial sequencing and alignment of the virus capsid gene (VP60). Nucleotide substitution was determined using nucleotides 6440-6780 of VP60. All other nucleotides in this sequence were identical to that of the original Czech strain V-351 (Meyers et al. 1991; Asgari et al. 1999 (Table 1) , showed several individuals that were classified as nvRHDV-LV, then RHDV, and then again as nvRHDV-LV through time (Table 5 ). This included several rabbits that were considered to have been recently challenged by RHDV. However, these authors acknowledge that~17% of cases can be misclassified when using their serological criteria. Similarly, we also found that~18% of cases were misclassified (Table 5 ). These findings may be, in part, due to cocirculation of antibodies to both RHDV and nvRHDV-LV, or to an attenuated strain of RHDV. Furthermore, either or both ELISAs could be cross-reacting to unknown antigens that are not RHDV in origin but which are common in rabbit sera. Equally, the observed serological profiles may simply reflect the variation in antibody responses between individuals. Further confounding factors are that immunologically RHD-positive rabbits may respond serologically when re-exposed to RHDV/nvRHDV-LV, and repeated exposure of rabbits to either form could result in the high IgG titres seen in some rabbits. Rabbits with marginally elevated IgG titres may reflect past exposure to both forms of the virus, and any differences in the observed serology could also be related to time since infection . Further, attributing the presence of IgA and/or IgM antibodies to recent RHDV infection and reinfection may not be so clear cut. The possibility that a less virulent, attenuated RHDV could also raise high IgA and/or IgM titres should be considered, even though the presence of such antibody isotypes has not been reported in the sera of Australian rabbits sampled before the spread of RHDV . The rabbits that survived inoculation with RHDV during our field release all had IgG titres ≥1:2560. This is consistent with observations from eastern Australian rabbits where regression analysis has revealed that mortality of RHDVinoculated rabbits declined with increasing IgG titres (P < 0.01) . Around 56-71% of these inoculated rabbits died when IgG titres were between 1 :40 and 1:2560 but no deaths occurred when IgG was >1:2560. Unfortunately, the number of inoculated rabbits during our field release was insufficient to undertake similar regression analysis.
It is possible that there may be only small differences in terms of their coat proteins between nvRHDV-LV and RHDV in Australia, and that differences in pathogenicity may be partially the result of differing abilities of each form to replicate systemically within the host. That is, the two forms are antigenically similar, but not identical, and appear genetically different to RCD (Capucci et al. 1996 (Capucci et al. , 1997 . Rabbits that do not appear to have developed detectable antibody by the cELISA may still induce cell-mediated immunity, which could afford some protection to the host. The two forms may also differ in their abilities to transmit and/or infect their hosts. It is also possible that, in the presence of virulent RHDV, there has been relatively strong selection for attenuated forms of nvRHDV-LV(s). However, any crossprotection resulting from infection with either form seems to be only partial as ~50% of our rabbits with the nvRHDV-LV serological profile succumbed to RHDV. This mortality is similar to that seen in rabbits from eastern Australia with a similar nvRHDV-LV serological profile when they were challenged with RHDV . However, the possible effects, either directly or indirectly, of climate and rabbit density on the epidemiology of both forms of the virus should not be discounted.
Although we do have the above caveats, we believe there is sufficient serological evidence to suggest that one or more nvRHDV-LVs were present in Australia before the introduction of RHDV, and that the non-virulent form(s) is impacting on the efficacy of RHDV in at least some regions of Australia. That is, the data collected so far are consistent with such a hypothesis. However, there are still many unanswered questions regarding nvRHDV-LV and its interaction with RHDV. For example, how and when do rabbits become infected? Can all rabbits be reinfected, and how long do the associated antibodies persist? Answers to such questions are required to enable maximisation of the impact of RHDV as a biological control agent for feral rabbits in Australia and New Zealand. They will also provide useful information regarding the interaction of viruses in their natural environment.
